OpenVSafe by OpenVAERS
Search V-safe

7G7-29781-02188

2 vaccinations 6 coded responses 19 check-ins 6 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
532 / WI
Registered
2021-01-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-07
    Registered in v-safe
  2. 2021-01-07
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-07
    Survey response — day 0, dose 1
    MedDRA: Aphasia, Disturbance in attention, Feeling abnormal — Feeling: Good · Site: Pain
    Free text: Mental side effects: feeling loopy, difficulty focusing and concentrating, fumble over words
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-16
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-21
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-28
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cognitive disorder — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Mild to moderate cognitive impairment (yesterday moderate, today mild)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  12. 2021-01-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Swelling/mild pain in axillary lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain — Feeling: Good
    Free text: Sore axillary lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-02-06
    Health check-in — day 7, dose 2
    Feeling: Good · Muscle or body aches
    Adult check-in
  15. 2021-02-14
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-19
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-26
    Survey response — day 28, dose 2
    MedDRA: Body temperature increased, Fatigue, Headache, Lymphadenopathy, Pain, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Headache, fatigue, congestion, mild body aches, slightly elevated temperature (no fever), swollen lymph node in neck
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-03-06
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-01
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-07-29
    Survey response — 6 months, dose 2
    MedDRA: Fatigue, Headache, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Sore throat, headache, congestion, runny nose, fatigue.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  22. 2022-01-30
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-07Pfizer-BioNTech
22021-01-28Pfizer-BioNTech

Free text

Release 1 — day 0, dose 1

2021-01-07

Systemic reaction (other): Mental side effects: feeling loopy, difficulty focusing and concentrating, fumble over words

Release 3 — days 1–6 daily, dose 2

2021-01-29

Systemic reaction (other): Mild to moderate cognitive impairment (yesterday moderate, today mild)

2021-01-31

Systemic reaction (other): Swelling/mild pain in axillary lymph nodes

2021-02-02

Systemic reaction (other): Sore axillary lymph nodes

Release 4 — day 28, dose 2

2021-02-26

Symptoms: Headache, fatigue, congestion, mild body aches, slightly elevated temperature (no fever), swollen lymph node in neck

Release 9 — 6 months, dose 2

2021-07-29

Symptoms: Sore throat, headache, congestion, runny nose, fatigue.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBody temperature increased ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDOropharyngeal pain ✓ · ✓
SDPain ✓ ✓ ✓
SDRespiratory tract congestion ✓ ✓ ✓
SDRhinorrhoea ✓ · ✓
SROAphasia ✓ ✓ ✓
SROCognitive disorder ✓ ✓ ✓
SRODisturbance in attention ✓ ✓ ✓
SROFeeling abnormal ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release